newsfilter
← Latest News
Business Wire·

Appili Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Appili Therapeutics Inc. (TSX:APLI, OTCQB:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Dr. Don Cilla, Appili